Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 12:07:54 UTC 2023
by
admin
on
Sat Dec 16 12:07:54 UTC 2023
|
| Protein Sub Type | |
| Sequence Type | COMPLETE |
| Record UNII |
SX1JPI95HB
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SX1JPI95HB
Created by
admin on Sat Dec 16 12:07:54 UTC 2023 , Edited by admin on Sat Dec 16 12:07:54 UTC 2023
|
PRIMARY | |||
|
Q04771
Created by
admin on Sat Dec 16 12:07:54 UTC 2023 , Edited by admin on Sat Dec 16 12:07:54 UTC 2023
|
PRIMARY |
| Glycosylation Type | HUMAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_82 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
INHIBITOR -> TARGET |
|
||
|
|
AGONIST -> TARGET |
Type I receptor ACVR1, type II receptor ACVR2A and BMP-7 agonist proteins must form a complex to initiate the canonical BMP signaling cascade.
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
LIGAND->TARGET |
|
||
|
AGONIST -> TARGET |
Type I receptor ACVR1, type II receptor ACVR2A and BMP-7 agonist proteins must form a complex to initiate the canonical BMP signaling cascade.
|
||
|
INHIBITOR -> TARGET |
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
inhibitor of both mutated ALK2 and wild type (wt)ALK2
|
||
|
INHIBITOR -> TARGET |
IC50
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|